﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2015v2.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2016-11-11T15:16:51-06:00</ReturnTs>
    <TaxPeriodEndDt>2015-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>911194016</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>CLARK NUBER PS</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>10900 NE 4TH STREET SUITE 1700</AddressLine1Txt>
        <CityNm>BELLEVUE</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>98004</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2015-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>911893957</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE MAX FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>MAXF</BusinessNameControlTxt>
      <PhoneNum>4257788660</PhoneNum>
      <USAddress>
        <AddressLine1Txt>200 NE PACIFIC STREET SUITE 103</AddressLine1Txt>
        <CityNm>SEATTLE</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>98105</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>PATRICIA GARCIA-GONZALEZ</PersonNm>
      <PersonTitleTxt>CEO</PersonTitleTxt>
      <PhoneNum>4257788660</PhoneNum>
      <SignatureDt>2016-11-11</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>JANE M SEARING</PreparerPersonNm>
      <PTIN>P00000565</PTIN>
      <PhoneNum>4254544919</PhoneNum>
      <PreparationDt>2016-11-10</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2015</TaxYr>
    <BuildTS>2017-02-10 21:41:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>PATRICIA GARCIA-GONZALEZ</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>200 NE PACIFIC STREET SUITE 103</AddressLine1Txt>
        <CityNm>SEATTLE</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>98105</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>4722293</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.THEMAXFOUNDATION.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1997</FormationYr>
      <LegalDomicileStateCd>WA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>INCREASE GLOBAL ACCESS TO TREATMENT, CARE, AND SUPPORT FOR PEOPLE LIVING WITH CANCER.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>7</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>6</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>12</TotalEmployeeCnt>
      <TotalVolunteersCnt>1000</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>1068789</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>2765925</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1831127</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1934951</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>3912</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>4598</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>18083</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>16819</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2921911</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>4722293</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>208073</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>671794</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>938120</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1134493</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>35736</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>1279713</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1171717</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2425906</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2978004</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>496005</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>1744289</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>2240467</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>4036871</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>53619</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>101612</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>2186848</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>3935259</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE MAX FOUNDATION IS A GLOBAL HEALTH ORGANIZATION THAT BELIEVES THAT ALL PEOPLE LIVING WITH CANCER HAVE THE RIGHT TO ACCESS THE BEST TREATMENT AND SUPPORT. THROUGH PERSONALIZED ACCESS SERVICES, QUALITY TRAINING AND EDUCATION, AND GLOBAL ADVOCACY EFFORTS, WE AIM TO HELP PEOPLE FACE CANCER WITH DIGNITY AND HOPE. OUR SERVICES ARE GLOBAL AND MULTIFACETED. WE PROVIDE EDUCATION AND TRAINING AT ALL LEVELS OF THE COMMUNITIES IN WHICH WE WORK. BY PARTNERING WITH INDUSTRY, NON-GOVERNMENTAL AGENCIES, HEALTH CARE PROVIDERS, AND NATIONAL CANCER PATIENT ORGANIZATIONS, WE ARE ABLE TO SUPPORT PEOPLE AND PROVIDE EFFECTIVE SOLUTIONS FOR ACCESS TO TREATMENT. THROUGH OUR GLOBAL ADVOCACY EFFORTS, WE WORK TO RAISE AWARENESS OF THE DISEASE AND DRAW ATTENTION TO THE NEEDS OF PEOPLE LIVING WITH CANCER. EVERY YEAR, OUR DEDICATED TEAM HELPS PEOPLE IN MORE THAN 100 COUNTRIES.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>2700740</ExpenseAmt>
      <GrantAmt>671794</GrantAmt>
      <RevenueAmt>1934951</RevenueAmt>
      <Desc>A KEY FOCUS OF THE ORGANIZATION IS EXPANDING ACCESS TO INNOVATIVE TREATMENTS FOR CANCER IN LOW AND MIDDLE INCOME COUNTRIES. OUR PRIMARY CLIENT IS A PATIENT AND HIS/HER FAMILY WHO IS ENROLLED IN ONE OF THE ACCESS SOLUTIONS WE DEVELOP OR MANAGE. WE ACT AS HEALTHCARE NAVIGATORS FOR THESE PATIENTS, HELPING THEM WALK THROUGH THE ACCESS PROGRAM ENVIRONMENT. IN ORDER TO OPTIMIZE TREATMENT, WE ALSO PROVIDE EMOTIONAL AND LOGISTICAL SUPPORT AND EDUCATION ONE ON ONE OR IN GROUPS, AND ADVOCATE ON THEIR BEHALF WHEN NEEDED. WE CREATE COMMUNITIES AROUND PATIENTS BY ESTABLISHING AND SUPPORTING PATIENT ORGANIZATIONS, AND SET UP AWARENESS INITIATIVES IN THE PATIENT'S COMMUNITY. WE USE A SOPHISTICATED PROGRAM WEB-ENGINE DEVELOPED IN-HOUSE TO ALLOW US TO CREATE INDIVIDUALIZED PROGRAM LIFE CYCLES TO MEET EACH PATIENT'S NEEDS. IN 2015 THE ORGANIZATION ADMINISTERED SIX UNIQUE PATIENT-ORIENTED PROGRAMS OF DIVERSE SCOPE AND FOCUS, IN PARTNERSHIP WITH INDUSTRY, GOVERNMENT AND PHYSICIANS IN 74 COUNTRIES, HELPING MORE THAN 38,140 PATIENTS WITH PATIENT NAVIGATION SERVICES, ONE ON ONE EMOTIONAL SUPPORT IN 75 COUNTRIES, PROVIDING ADVOCACY SERVICES TO 11,852 PATIENTS IN 65 COUNTRIES AND INFORMATIONAL REFERRALS TO 6,248 PATIENTS IN 21 COUNTRIES. THROUGH A PATIENT HELPLINE, WE SERVED 25,536 PATIENTS WITH COUNSELING AND EMOTIONAL SUPPORT, PROVIDED ADVOCACY SERVICES TO 5,661 PATIENTS AND INFORMATIONAL REFERRALS TO 4,027 PATIENTS.</Desc>
      <TotalProgramServiceExpensesAmt>2700740</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">0</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>1</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043500001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043500001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>1</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="RetDoc1043500001">1</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043500001">0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043500001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>9</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>12</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>1</ForeignFinancialAccountInd>
      <ForeignCountryCd>IN</ForeignCountryCd>
      <ForeignCountryCd>MY</ForeignCountryCd>
      <ForeignCountryCd>AR</ForeignCountryCd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>7</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>6</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>PATRICIA GARCIA-GONZALEZ</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>4257788660</PhoneNum>
        <USAddress>
          <AddressLine1Txt>200 NE PACIFIC STREET SUITE 103</AddressLine1Txt>
          <CityNm>SEATTLE</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98105</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>PATRICIA GARCIA-GONZALEZ</PersonNm>
        <TitleTxt>PRESIDENT, CEO</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>184145</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>10647</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TRACEY HIGGINS</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID TINGSTAD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBERT FARMER</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JERRY SCOTT</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GRANT RUBENSTEIN</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAULA BOULTBEE</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>184145</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>10647</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>2765925</AllOtherContributionsAmt>
      <NoncashContributionsAmt>1753851</NoncashContributionsAmt>
      <TotalContributionsAmt>2765925</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PATIENT CARE</Desc>
        <BusinessCd>624100</BusinessCd>
        <TotalRevenueColumnAmt>1880409</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1880409</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEDICAL TEST KITS</Desc>
        <BusinessCd>624100</BusinessCd>
        <TotalRevenueColumnAmt>54542</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>54542</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>1934951</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>4598</TotalRevenueColumnAmt>
        <ExclusionAmt>4598</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>7</TotalRevenueColumnAmt>
        <ExclusionAmt>7</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <OtherRevenueMiscGrp>
        <Desc>REIMBURSEMENTS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>15692</TotalRevenueColumnAmt>
        <ExclusionAmt>15692</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>697</TotalRevenueColumnAmt>
        <ExclusionAmt>697</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>HONORARIUM</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>423</TotalRevenueColumnAmt>
        <ExclusionAmt>423</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>16812</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>4722293</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1934951</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>21417</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <ForeignGrantsGrp>
        <TotalAmt>671794</TotalAmt>
        <ProgramServicesAmt>671794</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>172396</TotalAmt>
        <ProgramServicesAmt>159229</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9405</ManagementAndGeneralAmt>
        <FundraisingAmt>3762</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>48363</TotalAmt>
        <ProgramServicesAmt>48363</ProgramServicesAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>761212</TotalAmt>
        <ProgramServicesAmt>699382</ProgramServicesAmt>
        <ManagementAndGeneralAmt>44164</ManagementAndGeneralAmt>
        <FundraisingAmt>17666</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>91085</TotalAmt>
        <ProgramServicesAmt>84046</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5028</ManagementAndGeneralAmt>
        <FundraisingAmt>2011</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>61437</TotalAmt>
        <ProgramServicesAmt>56281</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3683</ManagementAndGeneralAmt>
        <FundraisingAmt>1473</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>65953</TotalAmt>
        <ManagementAndGeneralAmt>65953</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>380246</TotalAmt>
        <ProgramServicesAmt>380246</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>6103</TotalAmt>
        <ProgramServicesAmt>2710</ProgramServicesAmt>
        <ManagementAndGeneralAmt>679</ManagementAndGeneralAmt>
        <FundraisingAmt>2714</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>90200</TotalAmt>
        <ProgramServicesAmt>38579</ProgramServicesAmt>
        <ManagementAndGeneralAmt>51621</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>14930</TotalAmt>
        <ManagementAndGeneralAmt>14930</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>107386</TotalAmt>
        <ProgramServicesAmt>97903</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9483</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>157053</TotalAmt>
        <ProgramServicesAmt>140833</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8110</ManagementAndGeneralAmt>
        <FundraisingAmt>8110</FundraisingAmt>
      </TravelGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>30023</TotalAmt>
        <ProgramServicesAmt>20152</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9871</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>6314</TotalAmt>
        <ManagementAndGeneralAmt>6314</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>EDUCATION WORKSHOPS</Desc>
        <TotalAmt>282028</TotalAmt>
        <ProgramServicesAmt>282028</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>FOREIGN CURRENCY LOSS</Desc>
        <TotalAmt>19194</TotalAmt>
        <ProgramServicesAmt>19194</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BUS. LICENSE &amp; TAXES</Desc>
        <TotalAmt>11252</TotalAmt>
        <ManagementAndGeneralAmt>11252</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>1035</TotalAmt>
        <ManagementAndGeneralAmt>1035</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2978004</TotalAmt>
        <ProgramServicesAmt>2700740</ProgramServicesAmt>
        <ManagementAndGeneralAmt>241528</ManagementAndGeneralAmt>
        <FundraisingAmt>35736</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1570900</BOYAmt>
        <EOYAmt>2044267</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>16083</BOYAmt>
        <EOYAmt>4715</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>489448</BOYAmt>
        <EOYAmt>387809</EOYAmt>
      </AccountsReceivableGrp>
      <OthNotesLoansReceivableNetGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>234853</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>17176</BOYAmt>
        <EOYAmt>1195977</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>8460</BOYAmt>
        <EOYAmt>17568</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>305149</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>160428</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>134716</BOYAmt>
        <EOYAmt>144721</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>3684</BOYAmt>
        <EOYAmt>6961</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>2240467</BOYAmt>
        <EOYAmt>4036871</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>53619</BOYAmt>
        <EOYAmt>98646</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>2966</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>53619</BOYAmt>
        <EOYAmt>101612</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>1957354</BOYAmt>
        <EOYAmt>2477415</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>229494</BOYAmt>
        <EOYAmt>1457844</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>2186848</BOYAmt>
        <EOYAmt>3935259</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>2240467</BOYAmt>
        <EOYAmt>4036871</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>1744289</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>4122</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>1</AccountantCompileOrReviewInd>
      <AcctCompileOrReviewBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </AcctCompileOrReviewBasisGrp>
      <FSAuditedInd>0</FSAuditedInd>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>84917</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>502731</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>623457</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1068789</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2765925</CurrentTaxYearAmt>
        <TotalAmt>5045819</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>84917</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>502731</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>623457</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1068789</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2765925</CurrentTaxYearAmt>
        <TotalAmt>5045819</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>3502407</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>1543412</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus3YearsAmt>3</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>3535</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>4071</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>4605</CurrentTaxYearAmt>
        <TotalAmt>12214</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus1YearAmt>590</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1120</CurrentTaxYearAmt>
        <TotalAmt>1710</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>5059743</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>9900082</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.30500</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.37790</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsPY170Ind>X</ThirtyThrPctSuprtTestsPY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>MISCELLANEOUS INCOME - 2014 AMOUNT: $ 590. 2015 AMOUNT: $ 1,120.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>305149</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>160428</DepreciationAmt>
        <BookValueAmt>144721</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>144721</TotalBookValueLandBuildingsAmt>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>CENTRAL AMERICA AND THE CARIBBEAN</RegionTxt>
        <OfficesCnt>1</OfficesCnt>
        <EmployeeCnt>3</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>60000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EAST ASIA AND THE PACIFIC</RegionTxt>
        <OfficesCnt>3</OfficesCnt>
        <EmployeeCnt>9</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY, DIRECT DRUG DONATION</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>330000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>PATIENT GROUP GRANTS</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>5000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>NORTH AMERICA</RegionTxt>
        <OfficesCnt>2</OfficesCnt>
        <EmployeeCnt>3</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>64000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <OfficesCnt>2</OfficesCnt>
        <EmployeeCnt>2</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY, DIRECT DRUG DONATION, DIAGNOSTIC EQUIPMENT</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>415000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>SOUTH AMERICA</RegionTxt>
        <OfficesCnt>2</OfficesCnt>
        <EmployeeCnt>5</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>175000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PRGRM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>DIRECT DRUG DONATION</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>70000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>RUSSIA &amp; THE NEWLY INDEPENDENT STATES</RegionTxt>
        <OfficesCnt>1</OfficesCnt>
        <EmployeeCnt>1</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>PATIENT COUNSELING AND ADVOCACY</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>22000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <OfficesCnt>2</OfficesCnt>
        <EmployeeCnt>18</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SRVCS, GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>EDUCATIONAL WORKSHOPS, PATIENT COUNSELING AND ADVOCACY</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>281000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>11</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>23</SubtotalEmployeesCnt>
      <ContinutationTotalOfficeCnt>2</ContinutationTotalOfficeCnt>
      <ContinutationTotalEmployeeCnt>18</ContinutationTotalEmployeeCnt>
      <TotalOfficeCnt>13</TotalOfficeCnt>
      <TotalEmployeeCnt>41</TotalEmployeeCnt>
      <SubtotalSpentAmt>1141000</SubtotalSpentAmt>
      <ContinuationSpentAmt>281000</ContinuationSpentAmt>
      <TotalSpentAmt>1422000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EAST ASIA &amp; THE PACIFIC</RegionTxt>
        <PurposeOfGrantTxt>MEDICAL EQUIPMENT FOR CANCER DIAGNOSTIC PURPOSES</PurposeOfGrantTxt>
        <CashGrantAmt>0</CashGrantAmt>
        <MannerOfCashDisbursementTxt>N/A</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>18545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>DIAGNOSTIC EQUIPMENT</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>FAIR MARKET VALUE</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EAST ASIA &amp; THE PACIFIC</RegionTxt>
        <PurposeOfGrantTxt>MEDICAL EQUIPMENT FOR CANCER DIAGNOSTIC PURPOSES</PurposeOfGrantTxt>
        <MannerOfCashDisbursementTxt>N/A</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>18545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>DIAGNOSTIC EQUIPMENT</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>FAIR MARKET VALUE</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>CENTRAL AMERICA &amp; THE CARIBEEAN</RegionTxt>
        <PurposeOfGrantTxt>MEDICAL EQUIPMENT FOR CANCER DIAGNOSTIC PURPOSES</PurposeOfGrantTxt>
        <MannerOfCashDisbursementTxt>N/A</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>5000</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>DIAGNOSTIC EQUIPMENT</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>FAIR MARKET VALUE</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <PurposeOfGrantTxt>PATIENT GROUP CAPACITY BUILDING</PurposeOfGrantTxt>
        <CashGrantAmt>4228</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>2640</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>TRAVEL EXPENSES</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>FAIR MARKET VALUE</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>4</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>EAST ASIA &amp; THE PACIFIC</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>84818</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>56545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH AMERICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>32482</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>84818</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>56545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>48722</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUG</TypeOfAssistanceTxt>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>56545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>DRUB</TypeOfAssistanceTxt>
        <RegionTxt>SUB-SAHARAN AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <NonCashAssistanceAmt>56545</NonCashAssistanceAmt>
        <DescriptionOfNonCashAsstTxt>CANCER TREATMENT DRUG</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>WHOLESALE ACQUISITION COST</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <TransferToForeignCorpInd>1</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>1</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>PROTOCOL FOR GRANTMAKING 1.THE PROGRAM OFFICER MAKING GRANT REQUESTS WILL NEED TO DETERMINE WHO IS DIRECTLY INVOLVED IN THE EXCHANGE OF FUNDS. A) IF FUNDS GO DIRECTLY TO THE PATIENT OR THE PATIENT'S FAMILY, THE PATIENT NAME IS CHECKED AGAINST THE SPECIALLY DESIGNATED NATIONALS LIST (SDN). B) IF FUNDS GO DIRECTLY TO A LABORATORY, THE NAME OF THE LABORATORY AND THE INDIVIDUAL RECEIVING THE FUNDS ARE CHECKED. LIKEWISE, IF IT IS A BANK, THE NAME OF THE BANK AND THE INDIVIDUAL NAME ON THE ACCOUNT ARE CHECKED. C) OUR REGIONAL STAFF MEMBERS UNDERGO A RIGOROUS HIRING PROCESS. IN ADDITION, MS STAFF ARE PERIODICALLY CHECKED AGAINST THE SDN LIST. HOWEVER, IF FUNDS MOVE THROUGH THE HANDS OF MS STAFF TO OTHER INDIVIDUALS OR ENTITIES, THE TRANSACTION IS SUBJECT TO THE SAME PROTOCOL. MS STAFF INDICATE THE INDIVIDUAL OR ENTITY THAT IS DIRECTLY INVOLVED IN THE EXCHANGE OF FUNDS. 2. THE ADMINISTRATIVE ASSISTANT REVIEWS THE SDN LIST AND OFAC COUNTRY SANCTIONS TO DETERMINE IF: A) THE PATIENT OR INDIVIDUAL APPEARS ON THE SDN LIST. B) THE PATIENT OR INDIVIDUAL RESIDES IN A SANCTIONED OFAC COUNTRY THAT LIMITS THIS GRANT. 3. THE INDIVIDUAL PATIENT GRANTS FORM INDICATES WHICH NAME(S) WERE CROSS-REFERENCED WITH THE SDN LIST. 4. IF THE PATIENT OR COUNTRY SHOWS UP ON EITHER LIST, IT WILL BE BROUGHT TO THE CEO AND THE CEO ASSISTANT'S ATTENTION AND THE PROGRAM OFFICER WILL BE GIVEN INSTRUCTIONS ON HOW TO INFORM THE MAX STATION AND THE PROPOSED RECIPIENT THAT THE GRANT IS DENIED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON THE ACCRUAL BASIS OF ACCOUNTING.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <ClubDuesOrFeesInd>X</ClubDuesOrFeesInd>
      <WrittenPolicyRefTAndEExpnssInd>1</WrittenPolicyRefTAndEExpnssInd>
      <SubstantiationRequiredInd>1</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>PATRICIA GARCIA-GONZALEZ</PersonNm>
        <TitleTxt>PRESIDENT, CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>167744</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>10000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>6401</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>10647</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>194792</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 1A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MAX FOUNDATION PAYS FOR A COMPANY WIDE FITNESS CLUB MEMBERSHIP THAT ALL STAFF AND BOARD MEMBERS MAY MAKE USE OF. IT IS NOT TREATED AS TAXABLE INCOME.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>INES GARCIA-GONZALEZ</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SEE PART V</RelationshipDescriptionTxt>
        <TransactionAmt>48363</TransactionAmt>
        <TransactionDesc>SEE PART V</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS:</FormAndLineReferenceDesc>
        <ExplanationTxt>(A) NAME OF PERSON: INES GARCIA GONZALEZ(B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FAMILY MEMBER OF PATRICIA GARCIA-GONZALEZ, CEO.(D) DESCRIPTION OF TRANSACTION: EMPLOYMENT</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <DrugsAndMedicalSuppliesGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>128</ContributionCnt>
        <NoncashContributionsRptF990Amt>1753851</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>WHOLESALE ACQ. COST</MethodOfDeterminingRevenuesTxt>
      </DrugsAndMedicalSuppliesGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>1</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NUMBER IN COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 6, VOLUNTEERS:</FormAndLineReferenceDesc>
        <ExplanationTxt>IN 2015, THE ORGANIZATION HELD THREE CAPACITY BUILDING CONFERENCES FOR REPRESENTATIVES OF PATIENT ASSOCIATIONS FROM AFRICA AND THE MIDDLE EAST, LATIN AMERICA AND ASIA. THROUGH TRAVEL GRANTS, 84 REPRESENTATIVES OF PATIENT ASSOCIATIONS WERE ABLE TO ATTEND THESE EDUCATIONAL EVENTS. THE ORGANIZATION ALSO RAN TWO GLOBAL AWARENESS CAMPAIGNS; BY PROVIDING GRANTS TO LOCAL PATIENT ASSOCIATIONS, THESE ASSOCIATIONS HELD 87 EVENTS AIMED AT INCREASING AWARENESS OF CANCER. VOLUNTEERS HELPED TO ORGANIZE THE EVENTS, AS WELL AS PROVIDED SUPPORT DURING THE EVENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE TAX RETURN IS PREPARED BY AN OUTSIDE ACCOUNTANT. AFTER PREPARATION, THE CEO PERFORMS A REVIEW OF THE RETURN. THE RETURN IS THEN FILED WITH THE IRS. A COPY IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD HAS ADOPTED A CONFLICT OF INTEREST POLICY AND THE POLICY IS REVIEWED ON AN ANNUAL BASIS. EACH YEAR, BOARD MEMBERS MUST REVIEW THE POLICY AND DETERMINE IF ANY CONFLICT OF INTERESTS EXIST. NO BOARD MEMBER MAY VOTE ON ANY MATTER UNDER CONSIDERATION AT A BOARD MEETING IN WHICH SUCH BOARD MEMBER HAS A CONFLICT OF INTEREST. FURTHER, ANY BOARD MEMBER WITH A MATERIAL CONFLICT OF INTEREST IN ANY DECISION SHOULD BE ABSENT FROM THE ROOM DURING THE BOARD'S REVIEW, INCLUDING ITS VOTE, ON THE DECISION IN QUESTION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CEO HAS A CONTRACT WITH THE BOARD, LAST DATED AND APPROVED ON MAY 28, 2013. IN THIS CONTRACT, A BASE SALARY AND A YEARLY PERCENTAGE INCREASE HAS BEEN ESTABLISHED, AS WELL AS A YEARLY BONUS. IN JANUARY OF 2015, ORGANIZATION WIDE GUIDELINES FOR SALARY/COMPENSATION FOR CONTRACTORS WERE VOTED ON AND APPROVED BY THE BOARD. EMPLOYEE COMPENSATION REVIEWS OCCUR IN JANUARY OF EACH YEAR. MAX STATIONS, WHO WORK BY CONTRACT, ARE REVIEWED ON A SCHEDULE RELATED TO THEIR HIRING OR THE ACHIEVEMENT OF KNOWLEDGE OF EXPERIENCE GOALS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>MAX COUNTRY REPS: PROGRAM SERVICE EXPENSES 380,246. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 380,246.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>PRIOR PERIOD ADJUSTMENTS FOR PRIOR YEAR ACCRUALS 4,122.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043500001">
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>MAXSTATION MALAYSIA SDN BHD</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <ForeignAddress>
          <AddressLine1Txt>UNIT 1302 LOBBY 1 BLOCK A DAMAN</AddressLine1Txt>
          <CityNm>SELANGOR</CityNm>
          <CountryCd>MY</CountryCd>
        </ForeignAddress>
        <EIN>320492996</EIN>
        <PrimaryActivitiesTxt>PATIENT ORIENTED PROGRAMS</PrimaryActivitiesTxt>
        <LegalDomicileForeignCountryCd>MY</LegalDomicileForeignCountryCd>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>THE MAX FOUNDATION</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <EntityTypeTxt>C</EntityTypeTxt>
        <ShareOfTotalIncomeAmt>128207</ShareOfTotalIncomeAmt>
        <ShareOfEOYAssetsAmt>158164</ShareOfEOYAssetsAmt>
        <OwnershipPct>1.00000</OwnershipPct>
        <ControlledOrganizationInd>1</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>0</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>1</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>0</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>0</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>0</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>0</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>0</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MAXSTATION MALAYSIA SDN BHD</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>D</TransactionTypeTxt>
        <InvolvedAmt>234854</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>